文献速递眼底病与葡萄膜炎

伴视网膜下高反射物质的中心性浆液性脉络膜视网膜病变的临床特征与结局

Clinical Characteristics and Outcomes in Central Serous Chorioretinopathy With Subretinal Hyper-Reflective Material: MICRoN Report 6.
PubMed 文献 · Am J Ophthalmol · 2026-02-26

这项多中心回顾性队列研究分析了503只慢性中心性浆液性脉络膜视网膜病变(CSCR)患眼,其中103只伴有视网膜下高反射物质(SHRM)。SHRM组基线视力更差、影像学异常更显著,且并发黄斑新生血管和持续性视网膜下液的比例更高;尽管两组视力均有改善,SHRM眼最终神经感觉层脱离高度仍更高。

要点

  • 伴SHRM的CSCR患眼基线最佳记录视力更差(0.4±0.3 logMAR,约20/50)。
  • SHRM组并发黄斑新生血管和持续性视网膜下液的比例显著高于非SHRM组。
  • 非SHRM状态和联合治疗与视网膜下液持续存在的较低几率相关。

核心结论

  • 伴SHRM的CSCR患者初始视力更差,治疗后视力虽改善,但持续性视网膜下液和EZ丢失在SHRM眼中仍更常见。

研究设计与样本

  • 回顾性多中心临床队列研究,纳入503只CSCR患眼(103只伴SHRM,400只不伴SHRM)。

主要发现

  • SHRM组基线BRVA为0.4±0.3 logMAR(20/50),非SHRM组为0.2±0.3 logMAR(20/30)(p=.006)。
  • SHRM眼RPE改变更重(p=.04)、神经感觉层脱离更高(p<.001)、光感受器不规则更多(p=.004)、高反射灶更多(p<.001)、双层征更常见(p<.001)。
  • SHRM组并发黄斑新生血管(p=.01)和持续性视网膜下液(p<.001)的发生率更高。
  • 两组视力均有改善,但SHRM眼最终神经感觉层脱离高度仍更高(p<.001)。
  • 有激素暴露史和EZ丢失(消退后)的眼在高SHRM分级中更多。

关键数值与推荐

  • Logistic回归显示非SHRM状态和联合治疗与视网膜下液持续存在的较低几率相关。

临床怎么用

  • 对伴SHRM的CSCR患眼应加强随访,关注持续性视网膜下液和EZ丢失。
  • 联合治疗可能有助于降低视网膜下液持续存在的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the clinical features and longitudinal outcomes of chronic central serous chorioretinopathy (CSCR) presenting with subretinal hyperreflective material (SHRM). DESIGN: Retrospective, multicenter clinical cohort study from the Macula Society CSCR Study Group. PARTICIPANTS: This study included consecutive patients with a diagnosis of CSCR, with and without SHRM. METHODS: Baseline and final best-recorded visual acuity (BRVA) and multimodal imaging parameters were compared between SHRM and non-SHRM groups. MAIN OUTCOME MEASURES: Longitudinal changes in BRVA and imaging parameters in both groups; factors affecting subretinal fluid (SRF) persistence, and change in BRVA. RESULTS: A total of 503 eyes (103 with SHRM and 400 eyes without SHRM) were analyzed. The SHRM group showed poorer baseline BRVA (0.4 ± 0.3 logMAR; 20/50) compared to the non-SHRM group (0.2 ± 0.3 logMAR; 20/30) (p = .006). SHRM eyes demonstrated greater RPE alteration (p = .04), higher neurosensory retinal detachment (p < .001), more photoreceptor irregularities (p = .004), hyperreflective foci (p < .001), and double-layer sign (p < .001). The incidence of concurrent macular neovascularization (p = .01) and persistent subretinal fluid (p < .001) was higher in the SHRM group. Despite visual improvement in both groups, final height of neuro-sensory detachment (p < .001) remained higher in SHRM eyes. Eyes with a history of steroid exposure and ellipsoid zone (EZ) loss (post-resolution) were greater in higher SHRM grades. Logistic regression revealed non-SHRM status, and combination therapy had lower odds of SRF persistence. CONCLUSION: CSCR with SHRM presented with worse initial vision. Although vision improved after treatment, persistent SRF and EZ loss (in resolved cases) remain more frequent in SHRM eyes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Sahoo NK, Hasan N, Jacob N, et al. Clinical Characteristics and Outcomes in Central Serous Chorioretinopathy With Subretinal Hyper-Reflective Material: MICRoN Report 6. Am J Ophthalmol. 2026. PMID: 41763593. doi:10.1016/j.ajo.2026.02.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。